Rivaroxaban

Whakaahuatanga Poto:

Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP
Rivaroxaban Te whakakorikori Roto-whare TDP    


Taipitopito Hua

Tohu Hua

WHAKAMAHI HUA

Papamuri

Rivaroxaban, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2 -carboxamide, he aukati iti-ngota ngota kaha o te tauwehe Xa he tauwehe coagulation i te wahanga tino nui i roto i te ara coagulation toto hua i roto i te whakatipuranga o te thrombin me te hanganga o te clot.Ka herea e Rivaroxaban ki te Tyr288 i roto i te pute S1 o te tauwehe Xa na roto i te taunekeneke a Tyr288 me te whakakapi maota o te chlorothiophene moiety.Ka taea te whakakore i te aukati (koff = 5x10-3s-1), tere (kon = 1.7x107 mol/L-1 s-1), me te ahua o te kukū (Ki = 0.4 nmol/L).I tenei wa kei te akohia a Rivaroxaban mo te maimoatanga o te VTE, te aukati i nga kaupapa mate pukupuku i roto i nga turoro me te mate pukupuku mate pukupuku, te aukati i te whiu i roto i nga turoro me te fibrillation atrial.

Tohutoro

Ko Elisabeth Perzborn, Susanne Roehrig, Alexander Straub, Dagmar Kubitza, Wolfgang Mueck, me Volker Laux.Rivaroxaban: he aukati Xa tauwehe waha hou.Arterioscler Thromb Vasc Biol 2010;30(3): 376-381

Whakaahuatanga

Rivaroxaban (BAY 59-7939) he tino kahawhiriwhiri me te tika Factor Xa (FXa) inhibitor, te whakatutuki i te painga kaha i roto i te kaha anti-FXa (IC50 0.7 nM; Ki 0.4 nM).

 

In Vitro

Ko te Rivaroxaban (BAY 59-7939) he a-waha, he aukati tika mo te Factor Xa (FXa) i te whakawhanaketanga mo te aukati me te maimoatanga o te thrombosis arterial me te venous.Ko te Rivaroxaban he whakataetae te whakakore i te FXa tangata (Ki 0.4 nM) me te> 10 000-fold te whiriwhiringa nui atu i era atu proteases serine;ka aukati hoki i te mahi prothrombinase (IC50 2.1 nM).Rivaroxaban inhibits endogenous FXa more potently in human and rabbit plasma (IC50 21 nM) than rat plasma (IC50 290 nM).E whakaatu ana i nga paanga anticoagulant i roto i te plasma tangata, te ruarua o te wa prothrombin (PT) me te whakahohe i te wa thromboplastin wahanga i te 0.23 me te 0.69μM, ia.

 

Ko te Rivaroxaban (BAY 59-7939) he kaha me te whiriwhiri, te aukati FXa tika me te pai o te mahi in vivo me te pai o te koiora-waha.Rivaroxaban (BAY 59-7939), e whakahaerehia ana e te iv bolus i mua i te whakauru o te thrombus, ka whakaiti i te hanganga o te thrombus (ED50 0.1 mg / kg), te whakakore i te FXa, me te whakaroa i te horopeta PT i runga i te whakawhirinaki.Ko te PT me te FXa e pa ana ki te ED50 (te piki ake o te 1.8 me te 32% te aukati, ia).I te 0.3 mg/kg (te horopeta ka tata ki te aukati i te hanganga o te thrombus), ka whakaroahia e Rivaroxaban te PT (3.2).±0.5-fold) me te aukati i te mahi FXa (65±3%).

 

Rokiroki

Paura

-20°C

3 tau
 

4°C

2 tau
I te whakarewa

-80°C

6 marama
 

-20°C

1 marama

Hanganga matū

Rivaroxaban

Tiwhikete

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

TE WHAKAMAHI KOI

Quality management1

Tono18Ko nga kaupapa Aromātai Tauritenga Kounga kua whakaaetia4, a6kei te whakamanahia nga kaupapa.

Quality management2

Ko te punaha whakahaere kounga teitei o te ao kua whakatakoto he turanga pakari mo nga hoko.

Quality management3

Ko te tirotiro i te kounga ka haere i roto i te huringa ora katoa o te hua ki te whakarite i te kounga me te hua rongoa.

Quality management4

Ko te roopu Whakahaere Whakahaere Ngaio e tautoko ana i nga hiahia kounga i te wa o te tono me te rehitatanga.

WHAKAMAHI WHAKATANGA

cpf5
cpf6

Korea Countec Pounamu Whakapai Raina

cpf7
cpf8

Taiwan CVC Pounamu Packaging Raina

cpf9
cpf10

Itari CAM Board Packaging Raina

cpf11

Miihini Whakakii Fette Tiamana

cpf12

Hapanihi Viswill Tablet Detector

cpf14-1

Rūma Whakahaere DCS

HOANI

Te mahi tahi o te ao
International cooperation
Te mahi tahi a-whare
Domestic cooperation

  • Tōmua:
  • Panuku:

  • Tuhia to korero ki konei ka tukuna mai ki a matou

    Nga waahanga hua